Verywell Health on MSN6d
COVID Variant XEC Could Become Dominant Soon: How You Can Protect Yourself
Fact checked by Nick Blackmer The COVID-19 variant XEC, which has been spreading across Europe, now accounts for 17% of cases ...
Is the updated COVID vaccine a good match for the current variant and the emerging strain?
Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...
COVID XEC: What are the symptoms of the new variant and will the updated vaccine protect you? What to know
A new variant of COVID called XEC — a combination of two Omicron subvariants — is spreading in the middle of flu season.
Many more seniors are getting COVID shots this year, CDC reports
The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...
The major COVID variants we've seen so far and which one to look out for right now
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
theliberal.ie4d
Do you believe it? Experts issue symptoms of new “Covid XEC variant” ahead of winter surge
According to an update on Covid figures released by Ireland's health authority, the most recent form, known as XEC, is ...
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Miami Herald1d
Fall illness rising again this year. Here’s the latest on COVID, flu, RSV, pneumonia
There is currently no vaccine available ... omicron variant XEC rising as a fast-spreading variant slated to take over as the ...
Reuters1d
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...